Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to find out what effects (good and bad) that a combination of
treatment with chemotherapy, radiation therapy and surgery has on you and your pancreatic
cancer. The chemotherapy drugs to be used: Gemcitabine, Docetaxel, Oxaliplatin, 5-FU and
alpha-interferon. The goal is to decrease the size of the tumor, so that removal by surgery
can be performed. Current treatments for this stage of pancreas cancer offer less than ideal
results, with little opportunity for treatment with curative intent.